Robert D. E. Sewell

Robert D. E. Sewell

Auto-generated profile, based on publicly available information

Robert D. E. Sewell

Department of Pharmacy, CECOS University, Peshawar, 25000, Khyber Pakhtunkhwa, Pakistan

Research Focus & Metrics

Academic Career Length

53Years (1974-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
KMKhojasteh Malekmohammad
Khojasteh Malekmohammad
RSRobert D. E. Sewell
Robert D. E. Sewell
MRMahmoud Rafieian-kopaei
Mahmoud Rafieian-kopaei
Atherosclerosis is a chronic inflammatory disease which is a major cause of coronary heart disease and stroke in humans. It is characterized by intimal plaques and cholesterol accumulation in arterial walls. The side effects of currently prescribed synthetic drugs and their high cost in the treatment of atherosclerosis has prompted the use of alternative herbal medicines, dietary supplements, and antioxidants associated with fewer adverse effects for the treatment of atherosclerosis. This article aims to present the activity mechanisms of antioxidants on atherosclerosis along with a review of the most prevalent medicinal plants employed against this multifactorial disease. The wide-ranging information in this review article was obtained from scientific databases including PubMed, Web of Science, Scopus, Science Direct and Google Scholar. Natural and synthetic antioxidants have a crucial role in the prevention and treatment of atherosclerosis through different mechanisms. These include: The inhibition of low density lipoprotein (LDL) oxidation, the reduction of reactive oxygen species (ROS) generation, the inhibition of cytokine secretion, the prevention of atherosclerotic plaque formation and platelet aggregation, the preclusion of mononuclear cell infiltration, the improvement of endothelial dysfunction and vasodilation, the augmentation of nitric oxide (NO) bioavailability, the modulation of the expression of adhesion molecules such as vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) on endothelial cells, and the suppression of foam cell formation.


1 June 1998 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
AGA M Gray
A M Gray
PSP S J Spencer
P S J Spencer
RSR D E Sewell
R D E Sewell

1 April 2011 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
MGMarina A. Gruden
Marina A. Gruden
RSRobert D.E. Sewell
Robert D.E. Sewell
KYKiran Yanamandra
Kiran Yanamandra
TDTatyana V. Davidova
Tatyana V. Davidova
VKValerian G. Kucheryanu
Valerian G. Kucheryanu
Ludmilla A. Morozova-RocheLudmilla A. Morozova-Roche
Ludmilla A. Morozova-Roche

1 May 2007 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
MGMarina A. Gruden
Marina A. Gruden
TDTatyana B. Davidova
Tatyana B. Davidova
MMMantas Mališauskas
Mantas Mališauskas
RSRobert D.E. Sewell
Robert D.E. Sewell
NVNina I. Voskresenskaya
Nina I. Voskresenskaya
Ludmilla A. Morozova-RocheLudmilla A. Morozova-Roche
Ludmilla A. Morozova-Roche

1 August 1999 in European Journal of Pharmacology
Verified
Journal Article
Closed access
AGAlex M Gray
Alex M Gray
DPDavid M Pache
David M Pache
RSRobert D.E Sewell
Robert D.E Sewell